TranS1, which develops and designs devices for degenerative lower lumber spine conditions, admits no wrongdoing as part of the settlement, according to the report.
The settlement should be finalized within the next few months.
More Articles on Devices:
Life Spine Releases Lateral Retractor, Spacer Devices
NUI Galway Plans Release of OsteoAnchor Joint Technology
Drug-Device Combination Market to Reach $30.5B by 2017
